2020-2022 Biomedical Engineering Society (BMES) Cellular and Molecular (CMBE) Conference

2020-2022年生物医学工程学会（BMES）细胞与分子（CMBE）会议

基本信息

批准号：
10560463
负责人：
Jianping Fu
金额：
$ 1.3万
依托单位：
BIOMEDICAL ENGINEERING SOCIETY
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-12-24 至 2023-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10560463
关键词：
3-Dimensional Address Adoption Area Atlases Award Basic Science Biology Biomedical Engineering Cardiovascular system Cells Chemistry Communities Data Science Development Diagnostic Discipline Disparate Education and Outreach Emerging Technologies Engineering Environment Epigenetic Process Ethnic Origin Event Exposure to Faculty Fostering Funding Genomics Goals Guidelines Health Human Industry Journals Length Letters Life Location Medicine Mentors Methods Molecular Orthopedics Outcome Paper Pathway interactions Physiological Postdoctoral Fellow Publishing Puerto Rico Recruitment Activity Regulation Research Research Personnel Scientist Societies Strategic Planning Structure Students Techniques Technology Time Tissues Translating Translational Research Travel Underrepresented Minority Underrepresented Populations United States National Institutes of Health Universities Vision Woman biological systems career cellular engineering clinical translation extracellular graduate student human disease interdisciplinary collaboration interest meetings member new technology posters programs racial minority special interest group symposium tool university student

项目摘要

Abstract The goal of this application is to support travel awards for students, fellows, and early stage investigators (ESI) to attend the Cellular and Molecular Bioengineering (CMBE) Conference. The specific theme of the 2020 conference will be ‘Vision 2020: Emerging Technologies to Elucidate the Rules of Life. The choice of theme is intended to address the key problem of how the new emerging technologies can help us to engineer better biological systems to transform our understanding of rule of life, as well as translate new discoveries in ways that ultimately benefit human health. Recently, many new technologies have been developed such as genomic/epigenetic editing, single cell to tissue-level cell atlas, tools to manipulate extracellular environment, and methods to fabricate cell/tissue structure in 3D. Within this central theme, a broad spectrum of isolated groups has emerged from disparate disciplines but has not been fully engaged in the CMBE community. The need for this conference lies in the unique opportunity to bring these investigators together in one room for the first time to exchange ideas and brainstorm new combined strategies for pushing the field of molecular and cellular engineering forward to a new level of integration. The outcome of the conference will be increased technology sharing amongst researchers, as well as a new vision and strategic plan for engineering biological systems for basic science and clinical translation. The specific objectives of this R13 application are two-fold. The first is to provide support to eight ESI junior investigators and twelve postdoctoral fellows or graduate students, whose submitted papers will be selected for podium presentation on the basis of scientific merit, with a focus on promoting women and underrepresented minorities. The meeting will provide these investigators with essential exposure and mentoring to launch or expand their academic research careers. The second objective is to foster adoption of new technologies to the CMBE research community and promote the interdisciplinary collaboration. The meeting will provide a platform to expose researchers in engineering, chemistry, biology, and data science to the latest techniques and develop a pathway to increase the impact of CMBE research in human disease. Aim #1: Present transformative CMBE discoveries and techniques to a diverse engineering and biology audience. Invited speakers will discuss their latest research during their presentations, with a special emphasis on new principles or rules in engineering biological systems. Aim #2: Outline potential pathways to translate fundamental CMBE research into diagnostics and therapies in human disease. This will provide guidelines in how to connect researchers, and in fact the entire CMBE field, with clinicians and industry to increase translation of this research area. Outcomes will be published in a special issue of the BMES Cellular and Molecular Bioengineering Journal.

抽象的此应用程序的目标是支持学生、研究员和早期研究人员的旅行奖励（ESI）参加细胞和分子生物工程（CMBE）会议。 2020 年会议的主题是“2020 年愿景：阐明生活规则的新兴技术”。主题旨在解决新兴技术如何帮助我们的关键问题设计更好的生物系统来改变我们对生命规则的理解，并翻译最近，许多新技术以最终有益于人类健康的方式出现了新发现。已经开发出诸如基因组/表观遗传编辑、单细胞到组织水平的细胞图谱、操作工具细胞外环境以及以 3D 方式制造细胞/组织结构的方法。广泛的孤立群体来自不同的学科，但尚未充分参与其中这次会议的必要性在于为这些研究人员带来了独特的机会。第一次在一个房间里交流想法并集思广益，推动新的组合策略分子和细胞工程领域迈向新的融合水平。会议将增加研究人员之间的技术共享，以及新的愿景和战略用于基础科学和临床转化的工程生物系统计划。该 R13 应用程序的具体目标有两个：第一个是为 8 个 ESI 提供支持。初级研究员和十二名博士后研究员或研究生，其提交的论文将根据科学价值被选上讲台演讲，重点是促进妇女和会议将为这些调查人员提供必要的接触和机会。指导他们开展或扩展学术研究生涯的第二个目标是促进采用。将新技术引入 CMBE 研究界并促进跨学科合作。该会议将为工程、化学、生物学和数据科学领域的研究人员提供一个展示的平台最新技术并开发一条途径来增加 CMBE 研究对人类疾病的影响。目标 1：向不同的工程和生物学领域展示变革性的 CMBE 发现和技术受邀演讲者将在演讲中重点讨论他们的最新研究。关于工程生物系统的新原理或规则。目标 2：概述将基础 CMBE 研究转化为诊断和治疗的潜在途径这将为如何连接研究人员乃至整个 CMBE 领域提供指导，与圣人和工业界一起增加这一研究领域的翻译。结果将发表在《BMES 细胞和分子生物工程杂志》特刊上。